moreView todays social media effects on ORMPView the latest stocks trending across Twitter. Click to view dashboardSee who Oramed is hiring next, click here to view […]
[at noodls] – JERUSALEM, March 3, 2014 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, … moreView todays social media effects on ORMPView the latest stocks trending across Twitter. Click to view dashboardSee who Oramed is hiring next, click here to view […]
[at noodls] – JERUSALEM, March 3, 2014 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, … moreView todays social media effects on ORMPView the latest stocks trending across Twitter. Click to view dashboardSee who Oramed is hiring next, click here to view […]
moreView todays social media effects on ORMPView the latest stocks trending across Twitter. Click to view dashboardSee who Oramed is hiring next, click here to view […]
Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) made a new 52-week high of $16.38 today on traded volume of 1.02 million shares. The development-stage pharmaceutical company recently announced positive results from a clinical trial of its oral insulin capsule in type 1 diabetes patients. ORMP shares are trading in the range of $11.38 to $16.38 in the current trading session. The company has […]
